Design Therapeutics (DSGN) executive compensation, 2026 proxy

Pratik Shah, Ph.D., President, Chief Executive Officer and Chairperson, was paid $3.5M in fiscal 2025, up 349% from $789,800 the year before.

Filed
April 23, 2026
Annual meeting
June 9, 2026
Pay year
fiscal 2025
Named executives
3
CEO total pay
$3.5M+349% vs prior year
CEO Target Bonus
60%Percentage of annual base salary
COO Target Bonus
40%Percentage of annual base salary
Corporate Goal Achievement
100%Determined by Board of Directors

How Ph.D. was paid

$3.5M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary11%Bonus4%Option awards78%Non-equity incentive7%All other compensation0%

Named executive officers

ExecutiveTotal
Pratik Shah, Ph.D.President, Chief Executive Officer and Chairperson$3,544,300
Sean Jeffries, Ph.D.Chief Operating Officer$1,891,530
Chris M. Storgard, M.D.Chief Medical Officer$2,030,270

What changed and why

  • $3.5MCEO total compensation increased to $3,544,300 in 2025 due to option awards granted.
  • $395KPratik Shah received a base salary of $395,000 for 2025.
  • 100%Non-equity incentive plan compensation for the CEO was $237,000 based on 100% goal achievement.
  • $144KDiscretionary cash bonuses of $144,000 were awarded to the CEO for 2025 contributions.
  • $2.8MOption awards for the CEO totaled $2,754,300 in aggregate grant date fair value.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.